Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 14, Number 4—April 2008

Perspective

Bluetongue Epidemiology in the European Union

Claude Saegerman*Comments to Author , Dirk Berkvens†, and Philip S. Mellor‡
Author affiliations: *University of Liège, Liège, Belgium; †Institute of Tropical Medicine, Antwerp, Belgium; ‡Institute for Animal Health, Pirbright, Surrey, UK

Main Article

Table

Outbreaks of bluetongue in Europe, 1998–2005*†

Country Year of first outbreak BTV serotype(s) Main suspected or identified vector(s)
Albania 2002 9 Culicoides obsoletus, C. pulicaris
Bosnia–Herzegovina 2002 9 ND
Bulgaria 1999 9 C. obsoletus, C. pulicaris
Croatia 2001 9, 16 C. obsoletus, C. scoticus
Cyprus 2003 16 C. imicola, C. obsoletus,
Former Yugoslav Republic of Macedonia 2001 9 ND
France (Corsica) 2000 2, 4, 16‡ C. imicola, C. pulicaris, C. obsoletus
Greece 1998 1, 4, 9, 16 C. imicola, C. obsoletus
Italy 2000 1, 2, 4, 9, 16 C. imicola, C. obsoletus, C. pulicaris
Kosovo 2001 9 ND
Montenegro 2001 9 ND
Portugal 2004 2,§ 4 C. imicola, C. obsoletus, C. pulicaris
Serbia 2001 9 ND
Spain 2000 2 C. imicola,C. obsoletus, C. pulicaris
Turkey 1998 4, 9, 16 C. imicola,C. obsoletus, C. pulicaris

*BTV, Bluetongue virus; ND, no data recorded.
†Sources (5,710).
‡This is an insufficiently attenuated vaccine strain (11).
§This strain is indistinguishable from Onderstepoort BTV-2 live attenuated vaccine strain (7).

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO